Your browser doesn't support javascript.
loading
Relationship between serum urate and changes in dual-energy CT monosodium urate crystal volume over 1 year in people with gout: an individual participant data analysis.
Kelly, Brooke; Gamble, Greg D; Horne, Anne; Doyle, Anthony J; Drake, Jill; Aati, Opetaia; Son, Chang-Nam; Kalluru, Ramanamma; Latto, Kieran; Stamp, Lisa; Dalbeth, Nicola.
Afiliação
  • Kelly B; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Gamble GD; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Horne A; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Doyle AJ; Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, Auckland, Auckland, New Zealand.
  • Drake J; Te Whatu Ora Health New Zealand Waitaha Canterbury, Christchurch, Canterbury, New Zealand.
  • Aati O; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Son CN; Keimyung University College of Medicine, Daegu, Daegu, Korea (the Republic of).
  • Kalluru R; Te Whatu Ora Health New Zealand Waitemata, Takapuna, New Zealand.
  • Latto K; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Stamp L; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
  • Dalbeth N; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand n.dalbeth@auckland.ac.nz.
Ann Rheum Dis ; 2024 Aug 24.
Article em En | MEDLINE | ID: mdl-39168586
ABSTRACT

OBJECTIVES:

The dynamics of monosodium urate (MSU) crystal changes across a range of serum urate concentrations in people with gout are unknown. This study aimed to systematically examine the relationship between serum urate and changes in dual-energy CT (DECT) urate volume in people with gout and stable serum urate concentrations.

METHODS:

Individual participant data were analysed from three studies of people with gout. The time periods for the analysis were selected to identify study participants with serial DECT scans of both feet over a 12-month epoch of stable urate-lowering therapy and serum urate concentrations. Data from 251 study participants were analysed using a mixed models analysis of covariance approach according to mean serum urate cut-points and mean serum urate bands.

RESULTS:

For all mean serum urate cut-points assessed (0.24, 0.30, 0.36, 0.42 and 0.48 mmol/L), reductions in DECT urate volumes were observed below the cut-point. Increased DECT urate volumes were observed at or above the 0.48 mmol/L mean serum urate cut-point. Differences in the change in DECT volume were observed for the 0.42 mmol/L cut-point (p=0.0044) and the 0.48 mmol/L cut-point (p<0.0001). Significantly reduced DECT urate volumes were observed for the mean serum urate bands<0.24 mmol/L and 0.24-0.29 mmol/L and increased DECT urate volume was observed for the mean serum urate band≥0.48 mmol/L.

CONCLUSIONS:

Over 1 year, MSU crystal dissolution, as measured by DECT, occurs with mean serum urate bands of<0.24 mmol/L and 0.24-0.29 mmol/L while MSU crystal formation occurs with mean serum urate≥0.48 mmol/L.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article